FI862159A0 - Nya salter. - Google Patents

Nya salter.

Info

Publication number
FI862159A0
FI862159A0 FI862159A FI862159A FI862159A0 FI 862159 A0 FI862159 A0 FI 862159A0 FI 862159 A FI862159 A FI 862159A FI 862159 A FI862159 A FI 862159A FI 862159 A0 FI862159 A0 FI 862159A0
Authority
FI
Finland
Prior art keywords
stands
prevention
hydrogen
lower alkyl
pgi2
Prior art date
Application number
FI862159A
Other languages
English (en)
Other versions
FI82690C (fi
FI82690B (fi
FI862159A (fi
Inventor
Gabor Kovacs
Geza Galambos
Istvan Toemoeskoezi
Karoly Kanai
Peter Gyory
Peter Koermoeczy
Istvan Stadler
Laszlo Szekeres
Gyula Papp
Eva Udvary
Pal Hadhazy
Jeno Marton
Gyoergy Dorman
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of FI862159A0 publication Critical patent/FI862159A0/fi
Publication of FI862159A publication Critical patent/FI862159A/fi
Application granted granted Critical
Publication of FI82690B publication Critical patent/FI82690B/fi
Publication of FI82690C publication Critical patent/FI82690C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Steroid Compounds (AREA)
FI862159A 1985-05-29 1986-05-22 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 7-oxo-pg12-efedrinsalter. FI82690C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU205085 1985-05-29
HU852050A HU197733B (en) 1985-05-29 1985-05-29 Process for producing ephedrin-salts of 7-oxo-prosta-cyclin derivatives

Publications (4)

Publication Number Publication Date
FI862159A0 true FI862159A0 (fi) 1986-05-22
FI862159A FI862159A (fi) 1986-11-30
FI82690B FI82690B (fi) 1990-12-31
FI82690C FI82690C (fi) 1991-04-10

Family

ID=10957509

Family Applications (1)

Application Number Title Priority Date Filing Date
FI862159A FI82690C (fi) 1985-05-29 1986-05-22 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 7-oxo-pg12-efedrinsalter.

Country Status (23)

Country Link
US (1) US4735965A (fi)
EP (1) EP0205969B1 (fi)
JP (1) JPS61277650A (fi)
KR (1) KR860009031A (fi)
CN (1) CN1010587B (fi)
AT (1) ATE71093T1 (fi)
AU (1) AU588761B2 (fi)
CS (1) CS261894B2 (fi)
DD (1) DD244977A5 (fi)
DE (1) DE3683192D1 (fi)
DK (1) DK249686A (fi)
ES (1) ES8706624A1 (fi)
FI (1) FI82690C (fi)
GR (1) GR861390B (fi)
HU (1) HU197733B (fi)
IL (1) IL78849A (fi)
NO (1) NO171677C (fi)
NZ (1) NZ216339A (fi)
PL (1) PL148718B1 (fi)
PT (1) PT82657B (fi)
SU (2) SU1454250A3 (fi)
YU (1) YU46169B (fi)
ZA (1) ZA863801B (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8729153D0 (en) * 1987-12-14 1988-01-27 Efamol Ltd Fatty acid compositions
HU227157B1 (en) * 2001-07-30 2010-09-28 Chinoin Gyogyszer Es Vegyeszet Production of beraprost ester by selective oxidation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU502731B2 (en) * 1975-09-17 1979-08-09 The Upjohn Company Prostaglandin analogues
IT1088036B (it) * 1977-11-25 1985-06-04 Erba Carlo Spa 15-epi-prostaciclina e prostaciclina analoghi
US4258199A (en) * 1978-03-13 1981-03-24 Research Corporation Method for preparing cyclic ethers and thioethers including oxygen isomers and sulfur analogs of prostacyclin
US4330553A (en) * 1979-11-12 1982-05-18 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. 7-Oxo-PGI2 -derivatives and process for the preparation thereof and pharmaceutical compositions containing same
HU182012B (en) * 1979-11-12 1983-12-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing 6-substituted-7-oxo-pgi down 1 derivatives
DE3035454A1 (de) * 1980-09-18 1982-04-22 Schering Ag, 1000 Berlin Und 4619 Bergkamen 7-oxoprostacyclinderivate und verfahren zu ihrer herstellung
HU191264B (en) * 1984-01-13 1987-01-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu Process for production of derivatives of 7-oxo-prostacyclin with selective biological effect

Also Published As

Publication number Publication date
HU197733B (en) 1989-05-29
EP0205969A3 (en) 1989-04-19
FI82690C (fi) 1991-04-10
CN1010587B (zh) 1990-11-28
EP0205969A2 (de) 1986-12-30
ZA863801B (en) 1987-01-28
GR861390B (en) 1986-09-17
CS261894B2 (en) 1989-02-10
PT82657A (en) 1986-06-01
EP0205969B1 (de) 1992-01-02
CN86103741A (zh) 1987-02-18
SU1454250A3 (ru) 1989-01-23
YU90986A (en) 1988-02-29
ES555454A0 (es) 1987-07-01
IL78849A (en) 1990-01-18
NO862112L (no) 1986-12-01
FI82690B (fi) 1990-12-31
PT82657B (pt) 1988-03-03
JPS61277650A (ja) 1986-12-08
IL78849A0 (en) 1986-09-30
NO171677C (no) 1993-04-21
ES8706624A1 (es) 1987-07-01
DE3683192D1 (de) 1992-02-13
AU588761B2 (en) 1989-09-21
DD244977A5 (de) 1987-04-22
DK249686D0 (da) 1986-05-28
HUT40635A (en) 1987-01-28
ATE71093T1 (de) 1992-01-15
NZ216339A (en) 1989-08-29
DK249686A (da) 1986-11-30
KR860009031A (ko) 1986-12-19
AU5800186A (en) 1986-12-04
US4735965A (en) 1988-04-05
NO171677B (no) 1993-01-11
PL148718B1 (en) 1989-11-30
FI862159A (fi) 1986-11-30
YU46169B (sh) 1993-05-28
SU1447823A1 (ru) 1988-12-30

Similar Documents

Publication Publication Date Title
RU92004429A (ru) Производные 2-(1-пиперазинил)-4-фенил-цикло-алканопиридина
ES8603455A1 (es) Un metodo para preparar derivados de piperazina
ATE26112T1 (de) Isochinolin-sulfonamidderivate und verfahren fuer ihre herstellung.
DE3768141D1 (de) Elektrolytische loesung quaternaerer salze fuer elektrolytischen kondensator.
RU98123607A (ru) Применение топирамата или его производных для получения лекарственного средства для лечения маниакально-депрессивных биполярных расстройств
NO862635D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 7-oksabicykloheptan-substituerte diamider og deres kongenere prostaglandinanaloger.
FI842760A0 (fi) Menetelmä terapeuttisesti aktiivisten imidatsoliumyhdisteiden valmistamiseksi
DK1284A (da) Substituerede 4-aminomethylenchromaner eller -chromener eller syreadditionssalte deraf, deres fremstilling og anvendelse
ES539123A0 (es) Un compuesto de 3-indolcarboxamida
FI862159A (fi) Nya salter.
FR2404005A1 (fr) Analogues de la prostaglandine i2 et compositions pharmaceutiques les contenant
EP0144991A3 (en) Polymethosybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
RU95114440A (ru) Арил-бензоил-гуанидины, способ их получения, фармацевтическая композиция, способ ее получения
ATE63541T1 (de) N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel.
ATE45978T1 (de) Stabilisierung der aktivitaet von peroxidase in loesung.
ATE63908T1 (de) 1,5-benzothiazepinderivate, deren herstellung und deren verwendung in der therapie.
DE3788149D1 (de) Prostazyklin-(PGI2)-Analoge.
SE8601799L (sv) (-)-1beta-etyl-1alfa-hydroximetyl-1,2,3,4,6,7,12,12balfa-iktahydroindolo/2,3-a/-kinolizin, forfarande for dess framstellning och farmaceutiska beredningar innehallande densamma
DK603688A (da) Middel til behandling af blodhoejtryk og hjerteinsufficiens
IT1190398B (it) Processo per la preparazione di alfa aloalchil-aril-chetoni otticamente attivi
SE8601798D0 (sv) Process for the preparation of eburnamenine derivatives
CA1271198C (en) 5,6-EPOXY-7-OXABICYCLOPTANE SUBSTITUTION DERIVATIVES OF PROSTAGLANDIN ANALOGS
TH8140EX (th) สารประกอบที่มีผลยับยั้งกรดในกระเพาะอาหารและกรรมวิธีสำหรับเตรียมสารนั้น

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: CHINOIN GYOGUSZER ES VEGYESZETI TERMEKEK